Brief: Ascelia Pharma Completes Directed Share Issue
23/09/2025 07:44
Sept 23 (Reuters) - Ascelia Pharma AB ACELP.ST: SAID ON MONDAY COMPLETED DIRECTED SHARE ISSUE WITH GROSS PROCEEDS OF ABOUT SEK 30 MILLION SUBSCRIPTION PRICE OF SEK 3.50 PER SHARE CORRESPONDS TO DISCOUNT OF ABOUT 9.09% TO MONDAY'S CLOSING PRICE OF SEK 3.85 TO USE NET PROCEEDS TO FURTHER STRENGTHEN BALANCE SHEET, SUPPORTING PARTNERING ACTIVITIES AND TO EXTEND CASH RUNWAY INTO Q4 2026 Source text for Workspace: ACELP.ST Further company coverage: nNDL4yZHgK (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))